• Policy
• ‘Will raise ICER threshold for innovative new drugs’
• by Lee, Jeong-Hwan Oct 16, 2024 05:50am

• Policy
• Govt ‘is considering measures to overcome Korea Passing’
• by Lee, Jeong-Hwan Oct 16, 2024 05:50am

• Policy
• Stopping illegal online sales·advertisements of 'Wegovy'
• by Lee, Hye-Kyung Oct 16, 2024 05:50am

• Policy
• 'Will adjust the price of generic drugs through reevals'
• by Lee, Jeong-Hwan Oct 16, 2024 05:50am

• Policy
• Amgen starts negotiations to extend reimb of Kyprolis
• by Lee, Tak-Sun Oct 15, 2024 05:50am

• Policy
• Reduced reimb for medicines-containing choline alfoscerate
• by Lee, Tak-Sun Oct 15, 2024 05:49am

• Policy
• Will generics dominate the oral psoriasis treatment market?
• by Lee, Tak-Sun Oct 14, 2024 05:49am

• Policy
• NA-MFDS clash on the approval of abortion pills
• by Lee, Jeong-Hwan Oct 14, 2024 05:49am

• Policy
• Approval process for 'Leqembi' heavily debated
• by Lee, Hye-Kyung Oct 14, 2024 05:49am

• Policy
• Drug pricing negotiations for Qarziba gather pace
• by Lee, Tak-Sun Oct 14, 2024 05:49am